EFOMP policy statement NO. 19: Dosimetry in nuclear medicine therapy – Molecular radiotherapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EFOMP policy statement NO. 19: Dosimetry in nuclear medicine therapy – Molecular radiotherapy
Authors
Keywords
-
Journal
Physica Medica-European Journal of Medical Physics
Volume -, Issue -, Pages 103166
Publisher
Elsevier BV
Online
2023-11-04
DOI
10.1016/j.ejmp.2023.103166
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EFOMP Malaga Declaration 2023: An updated vision on Medical Physics in Europe
- (2023) Brenda Byrne et al. Physica Medica-European Journal of Medical Physics
- Guidance on medical physics expert support for nuclear medicine
- (2022) Louise Fraser et al. BRITISH JOURNAL OF RADIOLOGY
- A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study
- (2022) Marnix Lam et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients
- (2022) Anna Sundlöv et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
- (2022) Katarina Sjögreen Gleisner et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group
- (2022) Riad Salem et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Radionuclides for Targeted Therapy: Physical Properties
- (2022) Caroline Stokke et al. MOLECULES
- Dosimetric quantities of neuroendocrine tumors over treatment cycles with 177Lu-DOTA-TATE
- (2021) Daniel Roth et al. JOURNAL OF NUCLEAR MEDICINE
- Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
- (2021) Oliver Sartor et al. NEW ENGLAND JOURNAL OF MEDICINE
- A multicentre and multi-national evaluation of the accuracy of quantitative Lu-177 SPECT/CT imaging performed within the MRTDosimetry project
- (2021) Johannes Tran-Gia et al. EJNMMI Physics
- The internal dosimetry user group position statement on molecular radiotherapy
- (2021) Jonathan Gear et al. BRITISH JOURNAL OF RADIOLOGY
- Overview of commercial treatment planning systems for targeted radionuclide therapy
- (2021) Giuseppe Della Gala et al. Physica Medica-European Journal of Medical Physics
- A Systematic Review and Meta-Analysis of the Relationship Between the Radiation Absorbed Dose to the Thyroid and Response in Patients Treated with Radioiodine for Graves' Disease
- (2021) Jan Taprogge et al. THYROID
- EANM dosimetry committee series on standard operational procedures: a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization with 90Y microspheres
- (2021) Carlo Chiesa et al. EJNMMI Physics
- EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours
- (2020) Jonathan Gear et al. EJNMMI Physics
- Radiopharmaceutical therapy in cancer: clinical advances and challenges
- (2020) George Sgouros et al. NATURE REVIEWS DRUG DISCOVERY
- Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with 90Y in the SARAH Study
- (2020) Anne-Laure Hermann et al. RADIOLOGY
- Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD project
- (2020) Jan Taprogge et al. EJNMMI Physics
- Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
- (2020) Etienne Garin et al. Lancet Gastroenterology & Hepatology
- Multicentre Trials on Standardised Quantitative Imaging and Dosimetry for Radionuclide Therapies
- (2020) M. Lassmann et al. CLINICAL ONCOLOGY
- Physics aspects of setting up a multicenter clinical trial involving internal dosimetry of radioiodine treatment of differentiated thyroid cancer
- (2019) Jan Taprogge et al. The quarterly journal of nuclear medicine and molecular imaging
- Correlation of dose with toxicity and tumour response to 90Y- and 177Lu-PRRT provides the basis for optimization through individualized treatment planning
- (2018) Marta Cremonesi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations
- (2018) Jonathan I. Gear et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Dosimetry-based treatment for Graves’ disease
- (2018) Steve L. Hyer et al. NUCLEAR MEDICINE COMMUNICATIONS
- Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial
- (2018) Michela Del Prete et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- 124I PET Assessment of Response of Bone Metastases to Initial Radioiodine Treatment of Differentiated Thyroid Cancer
- (2016) W. Jentzen et al. JOURNAL OF NUCLEAR MEDICINE
- Radioembolization of hepatocarcinoma with 90Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology
- (2015) C. Chiesa et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy
- (2014) Lidia Strigari et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing 177Lu-DOTA-Octreotate Treatment
- (2012) M. Sandstrom et al. JOURNAL OF NUCLEAR MEDICINE
- Efficacy and Toxicity Related to Treatment of Hepatocellular Carcinoma with 90Y-SIR Spheres: Radiobiologic Considerations
- (2010) L. Strigari et al. JOURNAL OF NUCLEAR MEDICINE
- A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer
- (2009) Glenn D. Flux et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Whole-Body Dosimetry for Individualized Treatment Planning of 131I-MIBG Radionuclide Therapy for Neuroblastoma
- (2009) S. E. Buckley et al. JOURNAL OF NUCLEAR MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started